DermTech, Inc. (DMTK)
NASDAQ: DMTK · IEX Real-Time Price · USD
3.50
-0.20 (-5.41%)
At close:
Mar 17, 2023, 4:00 PM
3.61
+0.11 (3.14%)
Pre-market:
Mar 20, 2023, 9:04 AM EDT
DermTech Market Cap
DermTech has a market cap or net worth of $106.29 million as of March 20, 2023. Its market cap has decreased by -75.81% in one year.
Market Cap
106.29M
Enterprise Value
32.46M
1-Year Change
-75.81%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since August 10, 2017, DermTech, Inc.'s market cap has decreased from $589.12M to $106.29M, a decrease of -81.96%. That is a compound annual growth rate of -26.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 17, 2023 | 106.29M | -5.41% |
Mar 16, 2023 | 112.36M | 2.21% |
Mar 15, 2023 | 109.93M | 0.84% |
Mar 14, 2023 | 109.02M | -2.97% |
Mar 13, 2023 | 112.36M | 8.19% |
Mar 10, 2023 | 103.86M | -10.70% |
Mar 9, 2023 | 116.31M | -2.05% |
Mar 8, 2023 | 118.74M | -0.51% |
Mar 7, 2023 | 119.34M | -3.68% |
Mar 6, 2023 | 123.90M | -8.52% |
Mar 3, 2023 | 135.44M | 17.37% |
Mar 2, 2023 | 115.40M | -7.77% |
Mar 1, 2023 | 125.11M | 5.91% |
Feb 28, 2023 | 118.13M | 5.14% |
Feb 27, 2023 | 112.36M | -4.15% |
Feb 24, 2023 | 117.22M | 0.26% |
Feb 23, 2023 | 116.91M | -7.45% |
Feb 22, 2023 | 126.33M | 4.26% |
Feb 21, 2023 | 121.17M | -17.90% |
Feb 17, 2023 | 147.58M | -3.76% |
Feb 16, 2023 | 153.35M | -4.17% |
Feb 15, 2023 | 160.04M | -0.19% |
Feb 14, 2023 | 160.34M | -8.97% |
Feb 13, 2023 | 176.13M | 5.07% |
Feb 10, 2023 | 167.63M | -5.48% |
View and export this data all the way back to 2017.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pliant Therapeutics, Inc. | 1.60B |
MoonLake Immunotherapeutics | 901.94M |
Marinus Pharmaceuticals, Inc. | 337.23M |
Sanara MedTech Inc. | 332.23M |
Personalis, Inc. | 127.59M |
Hyperfine, Inc. | 94.35M |
Kronos Bio, Inc. | 85.92M |
Immunic, Inc. | 73.27M |
Lyra Therapeutics, Inc. | 64.61M |